Please ensure Javascript is enabled for purposes of website accessibility

The Motley Fool's Weekly Editors' Picks

By Kris Eddy - Updated Apr 6, 2017 at 11:27AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Three of the week's most educational, amusing, and enriching articles.

Fools were out and about this week in an investing world jam-packed with actions and ideas. Here are three articles you might find useful as you decide how to invest your money.

5 Stocks to Buy Before Apple
Apple (Nasdaq: AAPL)! Must we say more? Oh, OK.

"Too many investors get excited and jump into a stock without comparing and contrasting against other possibilities," writes Fool editor and writer Anand Chokkavelu. "Before you buy shares in the iPhone/iPad/iMac-maker Apple, let me give you one (hopefully) compelling reason to consider one of these five other stocks."

Click to the article to see what Anand has to say about stocks that might offer you more than Apple can. For instance, find out why he thinks the compelling reason to buy NVIDIA (Nasdaq: NVDA) is "bang for your buck."

3 Stocks to Play Biotech
Do you curse the drug companies every time you open your wallet at the pharmacy? Want to turn that frown upside-down? You could consider investing in biotech companies.

"[A] science background isn't really required to invest successfully here," notes Fool editor and writer Jim Mueller. "Instead, an appreciation for the binary events, the partnerships, and the size of the pipeline that can be turned into revenue will go a long ways toward putting you onto the road to success."

Click to the article for specific advice on what to look for when evaluating biotech stocks. Jim also selected three companies worth your attention: Keryx Biopharmaceuticals (Nasdaq: KERX), MannKind (Nasdaq: MNKD), and Immunomedics (Nasdaq: IMMU).

China's Best-Kept Secret
Sohu.com (Nasdaq: SOHU), which makes money from online gaming and online advertising in China, often flies beneath investors' radar. Longtime Fool contributor Rick Munarriz checked out the company's earnings report and found something interesting.

"[T]he real head-turning aspect of Sohu's report is that its Internet brand advertising business grew more quickly than its Changyou-driven gaming efforts," Rick wrote. "Sohu's $53.5 million in brand advertising is just 36% of its revenue mix. Online gaming commands a thicker 53% slice. However, [brand advertising is] certainly a significant part of Sohu's business, and a one-way ticket to higher multiples, chunkier share prices, and a large, attentive audience the next time an earnings report kicks out."

It pays to look beyond the big names that everyone knows about, such as search engine Baidu.com and online gamer Shanda Games in China.

Click to the story for Rick's take on what the future might hold for Sohu.com.

Baidu and Sohu.com are Motley Fool Rule Breakers recommendations. Apple and NVIDIA are Motley Fool Stock Advisor picks.

Fool online editor Kris Eddy owns no shares of any stocks mentioned in this article. Try any of our investing newsletters free for 30 days. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
AAPL
$172.10 (2.14%) $3.61
Sohu.com Inc. Stock Quote
Sohu.com Inc.
SOHU
$17.75 (0.06%) $0.01
NVIDIA Corporation Stock Quote
NVIDIA Corporation
NVDA
$187.09 (4.28%) $7.67
MannKind Corporation Stock Quote
MannKind Corporation
MNKD
$4.15 (1.97%) $0.08
Keryx Biopharmaceuticals, Inc. Stock Quote
Keryx Biopharmaceuticals, Inc.
KERX
Immunomedics, Inc. Stock Quote
Immunomedics, Inc.
IMMU

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/13/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.